JOEL BURWELL: Open Payments
NPI 1427012657 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$966 in 54 payments from 12 companies in 2025. Trend: 2023 $1,050 · 2024 $1,372 · 2025 $966
Food & beverage: $966
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $283 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| PFIZER INC. | 6 | $87 |
| Amgen Inc. | 5 | $86 |
| Viatris Specialty LLC | 4 | $84 |
| Lilly USA, LLC | 4 | $76 |
| Sumitomo Pharma America, Inc. | 3 | $50 |
| Xeris Pharmaceuticals, Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $35 |
| Abbott Laboratories | 2 | $32 |
Products named: AIRSUPRA, UBRELVY, VRAYLAR, YUPELRI, MOUNJARO, NURTEC ODT, OTEZLA, QULIPTA.
Industry payments across MS — which companies pay providers there.
